Brett Giroir

Brett Giroir has a diverse and impressive work experience. Brett is currently the Chief Executive Officer at Altesa BioSciences, where they are leading the development and commercialization of new drugs for respiratory viral diseases and global viral threats. Prior to this, they served as an Independent Director at OncoNano Medicine, Inc. In 2021, they were a member of the Social Empowerment Council at Global Blood Therapeutics and worked as a Distinguished Visiting Executive at Leavitt Partners.

In 2020, Giroir was the US Representative to the World Health Organization Executive Board at the U.S. Department of State. Brett also held the position of US Assistant Secretary for Health at the U.S. Department of Health and Human Services (HHS) from 2018 to 2021. Giroir has experience in the FDA, where they served as the Acting FDA Commissioner in 2019-2020.

Prior to their government roles, Giroir was the Chief Executive Officer of AlloVir and ViraCyte, LLC. Brett has also held academic positions, including Adjunct Professor of Pediatrics, Tropical Medicine, and Medical Ethics at Baylor College of Medicine, and Executive VP and CEO, and Professor at Texas A&M Health Science Center.

Overall, Brett Giroir has a strong background in healthcare leadership, policy-making, and business management.

Brett Giroir attended Jesuit High School of New Orleans from 1973 to 1978. Brett then pursued a Bachelor of Arts degree in Biology, graduating Magna Cum Laude from Harvard University between 1978 and 1982. Subsequently, Giroir attended The University of Texas Southwestern Medical School from 1982 to 1986, where they obtained their medical degree (M.D.) specializing in Medicine and was a member of the Alpha Omega Alpha medical honor society.